Phase II Trial of Cabozantinib Plus Erlotinib in Patients With Advanced Epidermal Growth Factor Receptor ( EGFR )-Mutant Non-small Cell Lung Cancer With Progressive Disease on Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy: A California Cancer Consortium Phase II Trial (NCI 9303)
Reckamp, Karen L, Frankel, Paul H, Ruel, Nora, Mack, Philip C, Gitlitz, Barbara J, Li, Tianhong, Koczywas, Marianna, Gadgeel, Shirish M, Cristea, Mihaela C, Belani, Chandra P, Newman, Edward M, Gandara, David R, Lara, Jr, Primo N
Published in Frontiers in oncology (11.03.2019)
Published in Frontiers in oncology (11.03.2019)
Get full text
Journal Article
Inhibition of MDR1 Overcomes Resistance to Brentuximab Vedotin in Hodgkin Lymphoma
Chen, Robert, Herrera, Alex F, Hou, Jessie, Chen, Lu, Wu, Jun, Guo, Yuming, Synold, Timothy W, Ngo, Vu N, Puverel, Sandrine, Mei, Matthew, Popplewell, Leslie, Yi, Shuhua, Song, Joo Y, Tao, Shu, Wu, Xiwei, Chan, Wing C, Forman, Stephen J, Kwak, Larry W, Rosen, Steven T, Newman, Edward M
Published in Clinical cancer research (01.03.2020)
Published in Clinical cancer research (01.03.2020)
Get full text
Journal Article
A Phase I Study of the Combination of Rituximab and Ipilimumab in Patients with Relapsed/Refractory B-Cell Lymphoma
Tuscano, Joseph M, Maverakis, Emanual, Groshen, Susan, Tsao-Wei, Denice, Luxardi, Guillaume, Merleev, Alexander A, Beaven, Anne, DiPersio, John F, Popplewell, Leslie, Chen, Robert, Kirschbaum, Mark, Schroeder, Mark A, Newman, Edward M
Published in Clinical cancer research (01.12.2019)
Published in Clinical cancer research (01.12.2019)
Get full text
Journal Article
Efficacy of the PARP Inhibitor Veliparib with Carboplatin or as a Single Agent in Patients with Germline BRCA1 - or BRCA2 -Associated Metastatic Breast Cancer: California Cancer Consortium Trial NCT01149083
Somlo, George, Frankel, Paul H, Arun, Banu K, Ma, Cynthia X, Garcia, Agustin A, Cigler, Tessa, Cream, Leah V, Harvey, Harold A, Sparano, Joseph A, Nanda, Rita, Chew, Helen K, Moynihan, Timothy J, Vahdat, Linda T, Goetz, Matthew P, Beumer, Jan H, Hurria, Arti, Mortimer, Joanne, Piekarz, Richard, Sand, Sharon, Herzog, Josef, Van Tongeren, Lily R, Ferry-Galow, Katherine V, Chen, Alice P, Ruel, Christopher, Newman, Edward M, Gandara, David R, Weitzel, Jeffrey N
Published in Clinical cancer research (01.08.2017)
Published in Clinical cancer research (01.08.2017)
Get full text
Journal Article
A Phase I Study of Veliparib in Combination with Metronomic Cyclophosphamide in Adults with Refractory Solid Tumors and Lymphomas
KUMMAR, Shivaani, JIUPINGJI, NEWMAN, Edward M, RUBINSTEIN, Larry, CHEN, Alice, YIPING ZHANG, LIHUA WANG, KINDERS, Robert J, PARCHMENT, Ralph E, TOMASZEWSKI, Joseph E, DOROSHOW, James H, MORGAN, Robert, LENZ, Heinz-Josef, PUHALLA, Shannon L, BELANI, Chandra P, GANDARA, David R, ALLEN, Deborah, KIESEL, Brian, BEUMER, Jan H
Published in Clinical cancer research (15.03.2012)
Published in Clinical cancer research (15.03.2012)
Get full text
Journal Article
Phase 1 study of the Aurora kinase A inhibitor alisertib (MLN8237) combined with the histone deacetylase inhibitor vorinostat in lymphoid malignancies
Siddiqi, Tanya, Frankel, Paul, Beumer, Jan H., Kiesel, Brian F., Christner, Susan, Ruel, Chris, Song, Joo Y., Chen, Robert, Kelly, Kevin R., Ailawadhi, Sikander, Kaesberg, Paul, Popplewell, Leslie, Puverel, Sandrine, Piekarz, Richard, Forman, Stephen J., Newman, Edward M.
Published in Leukemia & lymphoma (28.01.2020)
Published in Leukemia & lymphoma (28.01.2020)
Get full text
Journal Article
A phase I study of intravenous fenretinide (4-HPR) for patients with malignant solid tumors
Thomas, Jacob S., El-Khoueiry, Anthony B., Maurer, Barry J., Groshen, Susan, Pinski, Jacek K., Cobos, Everardo, Gandara, David R., Lenz, Heinz J., Kang, Min H., Reynolds, C. Patrick, Newman, Edward M.
Published in Cancer chemotherapy and pharmacology (01.04.2021)
Published in Cancer chemotherapy and pharmacology (01.04.2021)
Get full text
Journal Article
A phase 2 study of belinostat (PXD101) in patients with relapsed or refractory acute myeloid leukemia or patients over the age of 60 with newly diagnosed acute myeloid leukemia: a California Cancer Consortium Study
Kirschbaum, Mark H., Foon, Kenneth A., Frankel, Paul, Ruel, Christopher, Pulone, Bernadette, Tuscano, Joseph M., Newman, Edward M.
Published in Leukemia & lymphoma (01.10.2014)
Published in Leukemia & lymphoma (01.10.2014)
Get full text
Journal Article
Phase I Study of Fenretinide Delivered Intravenously in Patients with Relapsed or Refractory Hematologic Malignancies: A California Cancer Consortium Trial
Mohrbacher, Ann M, Yang, Allen S, Groshen, Susan, Kummar, Shivaani, Gutierrez, Martin E, Kang, Min H, Tsao-Wei, Denice, Reynolds, C Patrick, Newman, Edward M, Maurer, Barry J
Published in Clinical cancer research (15.08.2017)
Published in Clinical cancer research (15.08.2017)
Get full text
Journal Article
Untenable dosing: A common pitfall of modern DLT-targeting Phase I designs in oncology
Frankel, Paul H., Chung, Vincent, Xing, Yan, Longmate, Jeff, Groshen, Susan, Newman, Edward M.
Published in Current problems in cancer (01.12.2020)
Published in Current problems in cancer (01.12.2020)
Get full text
Journal Article
Phase I trial of belinostat in combination with 13-cis-retinoic acid in advanced solid tumor malignancies: a California Cancer Consortium NCI/CTEP sponsored trial
Luu, Thehang, Frankel, Paul, Beumer, Jan H., Lim, Dean, Cristea, Mihaela, Appleman, Leonard J., Lenz, Heinz J., Gandara, David R., Kiesel, Brian F., Piekarz, Richard L., Newman, Edward M.
Published in Cancer chemotherapy and pharmacology (01.12.2019)
Published in Cancer chemotherapy and pharmacology (01.12.2019)
Get full text
Journal Article
Erlotinib and Onalespib Lactate Focused on EGFR Exon 20 Insertion Non-Small Cell Lung Cancer (NSCLC): A California Cancer Consortium Phase I/II Trial (NCI 9878)
Riess, Jonathan W, Reckamp, Karen L, Frankel, Paul, Longmate, Jeffrey, Kelly, Karen A, Gandara, David R, Weipert, Caroline M, Raymond, Victoria M, Keer, Harold N, Mack, Philip C, Newman, Edward M, Lara, Primo N
Published in Clinical lung cancer (01.11.2021)
Published in Clinical lung cancer (01.11.2021)
Get full text
Journal Article
Phase I Study of Pazopanib in Patients with Advanced Solid Tumors and Hepatic Dysfunction: A National Cancer Institute Organ Dysfunction Working Group Study
SHIBATA, Stephen I, CHUNG, Vincent, O'NEIL, Bert H, SARANTOPOULOS, John, LORUSSO, Patricia, RUDEK, Michelle A, DOWLATI, Afshin, MULKERIN, Daniel L, BELANI, Chandra P, GANDHI, Leena, LAU, S. Cecilia, IVY, S. Percy, SYNOLD, Timothy W, NEWMAN, Edward M, LONGMATE, Jeffrey A, BENJAMIN SUTTLE, A, OTTESEN, Lone H, LENZ, Heinz-Josef, KUMMAR, Shivaani, HARVEY, R. Donald, HAMILTON, Anne L
Published in Clinical cancer research (01.07.2013)
Published in Clinical cancer research (01.07.2013)
Get full text
Journal Article
Intravenous 5-fluoro-2′-deoxycytidine administered with tetrahydrouridine increases the proportion of p16-expressing circulating tumor cells in patients with advanced solid tumors
Coyne, Geraldine O.’Sullivan, Wang, Lihua, Zlott, Jennifer, Juwara, Lamin, Covey, Joseph M., Beumer, Jan H., Cristea, Mihaela C., Newman, Edward M., Koehler, Stephen, Nieva, Jorge J., Garcia, Agustin A., Gandara, David R., Miller, Brandon, Khin, Sonny, Miller, Sarah B., Steinberg, Seth M., Rubinstein, Larry, Parchment, Ralph E., Kinders, Robert J., Piekarz, Richard L., Kummar, Shivaani, Chen, Alice P., Doroshow, James H.
Published in Cancer chemotherapy and pharmacology (01.05.2020)
Published in Cancer chemotherapy and pharmacology (01.05.2020)
Get full text
Journal Article
A phase I, pharmacokinetic, and pharmacodynamic evaluation of the DNA methyltransferase inhibitor 5-fluoro-2′-deoxycytidine, administered with tetrahydrouridine
Newman, Edward M., Morgan, Robert J., Kummar, Shivaani, Beumer, Jan H., Blanchard, M. Suzette, Ruel, Christopher, El-Khoueiry, Anthony B., Carroll, Mary I., Hou, Jessie M., Li, Chun, Lenz, Heinz J., Eiseman, Julie L., Doroshow, James H.
Published in Cancer chemotherapy and pharmacology (01.03.2015)
Published in Cancer chemotherapy and pharmacology (01.03.2015)
Get full text
Journal Article
Pharmacodynamics (PD) and pharmacokinetics (PK) of E7389 (eribulin, halichondrin B analog) during a phase I trial in patients with advanced solid tumors: a California Cancer Consortium trial
Morgan, Robert J., Synold, Timothy W., Longmate, Jeffrey A., Quinn, David I., Gandara, David, Lenz, Heinz-Josef, Ruel, Christopher, Xi, Bixin, Lewis, Michael D., Colevas, A. Dimitrios, Doroshow, James, Newman, Edward M.
Published in Cancer chemotherapy and pharmacology (01.11.2015)
Published in Cancer chemotherapy and pharmacology (01.11.2015)
Get full text
Journal Article
A phase II study of vascular endothelial growth factor trap (Aflibercept, NSC 724770) in patients with myelodysplastic syndrome: a California Cancer Consortium Study
Kirschbaum, Mark H., Frankel, Paul, Synold, Timothy W., Zain, Jasmine, Claxton, David, Tuscano, Joseph, Newman, Edward M., Gandara, David R., Lara, Primo N.
Published in British journal of haematology (01.02.2018)
Published in British journal of haematology (01.02.2018)
Get full text
Journal Article
Model of a Queuing Approach for Patient Accrual in Phase 1 Oncology Studies
Frankel, Paul H, Chung, Vincent, Tuscano, Joseph, Siddiqi, Tanya, Sampath, Sagus, Longmate, Jeffrey, Groshen, Susan, Newman, Edward M
Published in JAMA network open (01.05.2020)
Published in JAMA network open (01.05.2020)
Get full text
Journal Article